Related Experiment Video
Updated: Aug 8, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage
Annarita Nappi1, Caterina Miro1, Antonio Pezone2
1Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131, Naples, Italy.
Abstract:
The Thyroid Hormone (TH) activating enzyme, type 2 Deiodinase (D2), is functionally required to elevate the TH concentration during cancer progression to advanced stages. However, the mechanisms regulating D2 expression in cancer still remain poorly understood. Here, we show that the cell stress sensor and tumor suppressor p53 silences D2 expression, thereby lowering the intracellular THs availability. Conversely, even partial loss of p53 elevates D2/TH resulting in stimulation and increased fitness of tumor cells by boosting a significant transcriptional program leading to modulation of genes involved in DNA damage and repair and redox signaling. In vivo genetic deletion of D2 significantly reduces cancer progression and suggests that targeting THs may represent a general tool reducing invasiveness in p53-mutated neoplasms.
Insights
The tumor suppressor p53 normally silences the thyroid hormone (TH) activating enzyme, type 2 deiodinase (D2). Loss of p53 increases D2 and TH, promoting cancer cell growth and fitness.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Type 2 deiodinase (D2) activates thyroid hormone (TH) and is crucial for cancer progression.
- Mechanisms regulating D2 in cancer are not well understood.
Purpose of the Study:
- To investigate the role of p53 in regulating D2 expression in cancer.
- To understand how p53-mediated D2 regulation impacts tumor cell behavior.
Main Methods:
- Utilized cell culture and in vivo models to study p53 and D2 interactions.
- Analyzed gene expression and tumor progression in response to p53 and D2 modulation.
Main Results:
- The tumor suppressor p53 directly silences D2 expression, reducing intracellular TH availability.
- Loss of p53 function leads to elevated D2 and TH levels, enhancing tumor cell fitness.
- Elevated TH promotes a transcriptional program involving DNA repair and redox signaling.
- In vivo deletion of D2 significantly inhibited cancer progression in p53-mutated models.
Conclusions:
- p53 acts as a negative regulator of D2 in cancer.
- Targeting TH signaling may be a therapeutic strategy for p53-mutated cancers.
- D2-mediated TH signaling supports tumor cell adaptation and progression.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

